Universal Ibogaine Inc.
IBO.V
TSX
01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
---|---|---|---|---|---|
Net Income | -88.71% | -23.51% | 15.38% | 75.03% | 83.08% |
Total Depreciation and Amortization | 4.30% | 7.48% | 14.55% | 14.48% | 10.17% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 431.92% | 158.42% | 115.90% | -84.22% | -94.01% |
Change in Net Operating Assets | -176.59% | -172.01% | -145.34% | 84.23% | 233.38% |
Cash from Operations | -143.79% | -7.59% | 24.49% | 74.40% | 88.25% |
Capital Expenditure | 60.14% | 83.82% | 78.47% | 78.78% | 75.42% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | 60.14% | 83.82% | 78.47% | -125.98% | -140.54% |
Total Debt Issued | -- | -- | -- | -100.00% | 92.89% |
Total Debt Repaid | -111.71% | -148.02% | -213.35% | 20.16% | 76.14% |
Issuance of Common Stock | 190.70% | 1,430.00% | 202.13% | 161.35% | -22.67% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -240.63% | -- | -- | -- | -- |
Cash from Financing | 39.51% | 49.57% | -7.59% | -1.56% | 139.69% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -155.40% | 88.22% | 114.32% | 107.04% | 105.72% |